The first ever virtual #WHA73 and understandably focussed on #COVID19 but pleased to see Member States recognising that #cancer and the other #NCDs are still major global health issues.

#2019WCLS : #Access to #cancer medicines is a global #publichealth issue. ESMO is prioritising this issue with numerous initiatives; ESMO Clinical Practice Guidelines, #ESMO -MCBS, actions on #biosimilars , recommendations to prevent #medicineshortages . bit.ly/2BcLFJw

A recent analysis of #NCCPs by UICC showed that delivery of #cancer treatment services was not adequately addressed by countries. Discussions on how we can ensure that #cancer treatment reaches the people who need it are taking place now at the #2019WCLS . World Health Organization (WHO) ESMO - Eur. Oncology Pfizer Inc.